Takeda Pharmaceutical (TYO:4502) will use biochemical discovery technology from Metabolon to find new therapeutic targets and biomarkers. No financial terms of the research alliance were disclosed. But Metabolon said that the Japanese pharma giant will integrate Metabolon’s biochemical technology into Takeda’s R&D programs with the goal of accelerating development. Metabolon’s platform technology discovers biomarkers, chemical […]
Diagnostics firm Metabolon has raised $13.1 million in a fourth round of financing and in doing so has signaled intentions to eventually pursue an initial public stock offering. Metabolon added new investor Keating Capital, a a business development company that focuses on investments in companies “committed to and capable of becoming public.” Joining Keating in […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.